Regeneron Pharmaceuticals is investing €310m into its Limerick facility, adding 200 jobs to its bioprocessing campus by the end of 2017.
The Industrial Operations and Product Supply (IOPS) bioprocessing campus is the company’s first outside of the US and already employs 300 people.
This will bring the total investment from the company to €575m, with the site soon to be home to the largest-scale bulk biologics production facility in Ireland.
Recruitment is already underway to hire for high-end specialist jobs in commercial manufacturing, process sciences, quality assurance/control and various support functions for scientists, chemists and technicians.
Jobs in Limerick
“The Limerick facility will play an essential role in ensuring Regeneron delivers on our mission to consistently and repeatedly bring new medicines to patients with serious diseases,” said Leonard Schleifer, president and CEO of the company.
Regeneron only signed its first contract in Ireland a couple of years ago, after buying the site off Dell. The 400,000 sq ft biologics production facility is now operational, with the first production line on track to enter validation before the end of 2015.
Dan Van Plew from @regeneron talking about the 200 new jobs for Limerick #WhyIreland pic.twitter.com/G1pr1oiDJL
— Kevin Sammon (@SammonKevin) October 19, 2015
“The entire community has gone out of its way to welcome us and help us create the momentum we need to build this site,” said Dan Van Plew, SVP and GM of Regeneron’s IOPS.
“Our people – your countrymen – have done something remarkable. In less than two years we have brought a dormant building back to life, and are well on our way to building a complex, high-quality facility in industry-leading time.”
Looking for tech jobs in Ireland? Check out our Featured Employers section for information on companies hiring right now.
Main image via Shutterstock
